No Data
No Data
Sector Update: Health Care Stocks Steady Premarket Thursday
Health care stocks were steady premarket Thursday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. Arvinas (ARVN) shares were up more than
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE:PFE) and AstraZeneca Plc (NASDAQ:AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, j
Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio
By Colin Kellaher Johnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare giant's dermatology p
Johnson & Johnson to Acquire Proteologix for $850 Million
Johnson & Johnson: Proteologix's Portfolio Includes PX128, a Bispecific Antibody Targeting IL-13 Plus TSLP >JNJ
Johnson & Johnson: Proteologix's Portfolio Includes PX128, a Bispecific Antibody Targeting IL-13 Plus TSLP >JNJ
Johnson & Johnson To Acquire Proteologix, Inc. To Lead In Atopic Dermatitis Treatment >JNJ
Johnson & Johnson To Acquire Proteologix, Inc. To Lead In Atopic Dermatitis Treatment >JNJ
No Data